AMARIN ANNOUNCES COMPLETION OF $70 MILLION PRIVATE PLACEMENT Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about AMARIN ANNOUNCES COMPLETION OF $70 MILLION PRIVATE PLACEMENT
AMARIN APPOINTS MEDPACE AS CRO FOR TWO PHASE 3 CARDIOVASCULAR TRIALS Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about AMARIN APPOINTS MEDPACE AS CRO FOR TWO PHASE 3 CARDIOVASCULAR TRIALS
AMARIN APPOINTS JOHN F. THERO AS CHIEF FINANCIAL OFFICER Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about AMARIN APPOINTS JOHN F. THERO AS CHIEF FINANCIAL OFFICER
AMARIN CORP IS FIRST SMALL BIOPHARMACEUTICAL COMPANY TO JOIN SAFE-BIOPHARMA ASSOCIATION Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about AMARIN CORP IS FIRST SMALL BIOPHARMACEUTICAL COMPANY TO JOIN SAFE-BIOPHARMA ASSOCIATION
AMARIN CORPORATION APPOINTS INDUSTRY VETERAN JOSEPH ZAKRZEWSKI AS EXECUTIVE CHAIRMAN Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about AMARIN CORPORATION APPOINTS INDUSTRY VETERAN JOSEPH ZAKRZEWSKI AS EXECUTIVE CHAIRMAN
AMARIN TO PRESENT AT TWO UPCOMING INVESTOR CONFERENCES Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about AMARIN TO PRESENT AT TWO UPCOMING INVESTOR CONFERENCES
